Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Thomas Held

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3913-4693; OpenAlex author ID A5042791450. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Proton therapy for pancreatic cancer: real-world single-center experience of efficacy, toxicity, and predictors of outcome. Co-author DOI 10.3389/fonc.2026.1710943↗
  2. Immunohistochemical profiling of liver metastases and matched-pair analysis in patients with metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2019.09.005↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ahmed Gawish · 1 shared paper, 2026 · strength 0.26
  2. Fabian Eberle · 1 shared paper, 2026 · strength 0.26
  3. Philipp Lishewski · 1 shared paper, 2026 · strength 0.26
  4. Daniel Habermehl · 1 shared paper, 2026 · strength 0.26
  5. Carlos Fernández Moro · 1 shared paper, 2019 · strength 0.09
  6. Marco Del Chiaro · 1 shared paper, 2019 · strength 0.09
  7. Rainer Lothar Heuchel · 1 shared paper, 2019 · strength 0.09
  8. Markus Wolfgang Büchler · 1 shared paper, 2019 · strength 0.09
  9. Oliver Strobel · 1 shared paper, 2019 · strength 0.09
  10. Matthias J. Löhr · 1 shared paper, 2019 · strength 0.09
  11. Caroline Sophie Verbeke · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.